ICER is proud to work with renown academics in the fields of clinical evidence synthesis and economic modeling. Here is a selection of the experts that we routinely collaborate with to develop our reports:
- Grace Lin, MD, Associate Professor of Medicine and Health Policy, University of California, San Francisco
- Dan Ollendorf, PhD, Director, Value Measurement & Global Health Initiatives Center for the Evaluation of Value and Risk in Health, Tufts University Medical Center
- Jeffrey A. Tice, MD, Department of Medicine, Division of General Internal Medicine, University of California San Francisco
- Steve Atlas, MD, Associate Professor of Medicine, Harvard Medical School, Director of Practice-Based Research and Quality Improvement, Division of General Internal Medicine, Massachusetts General Hospital
- Dan Touchette, PharmD, MA, Associate Professor, University of Illinois at Chicago
- Josh Carlson, PhD, Associate Director of the Graduate Program, The CHOICE Institute, University of Washington
- R. Brett McQueen, PhD, Assistant Professor at University of Colorado
- Ryan Hansen, PhD, Assistant Professor, Department of Pharmacy; Adjunct Research Assistant Professor, Department of Health Services, School of Public Health; Associate Faculty, Harborview Injury Prevention Research Center; Affiliate Investigator, Group Health Research Institute
- Surrey Walton, PhD, Associate Professor of Pharmacy Administration, University of Illinois at Chicago
- Surya Singh, MD, President & Owner, Singh Healthcare Advisors, LLC and Adjunct Instructor of Medicine, Harvard Medical School (Profile)
Technology Partner for ICER Analytics’ Interactive Modeler
- Oleksandr Topachevskyi, PGDip, Founder & Health Economist, Digital Health Outcomes (Profile)
Health Economics Council
To ensure that all reports incorporate the most up-to-date methods and best practices in health economics, ICER collaborates with an academic council of experts, leveraging their expertise to support ICER’s work in assessing drugs and other interventions. Currently, ICER’s health economics partners include:
The University of Washington School of Pharmacy’s Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute
The CHOICE Institute conducts research and provides graduate and external training in health outcomes and policy research on health care technologies, with a focus on drugs, diagnostics, and devices. The overall goal of the program is to generate evidence that improves health care decisions for patients, clinicians, payers, industry and government organizations. The CHOICE Institute is a nationally and internationally recognized center for pharmaceutical economics, drug safety, and pharmaceutical policy research. Read more about this collaboration here.
The University of Colorado’s Skaggs School of Pharmacy and Pharmaceutical Sciences’ Center for Pharmaceutical Outcomes Research (CePOR)
The major goal of CePOR is to promote training and interdisciplinary research collaborations in the areas of pharmacoeconomics, health services and systems research, drug policy, health benefits design, pharmacoepidemiology, and drug safety. Read more about this collaboration here.
The University of Illinois at Chicago College of Pharmacy’s Center for Pharmacoepidemiology and Pharmacoeconomic Research (CPR)
The goal of the Center is to advance understanding of the impact of pharmacy and health care services, products, and policy by conducting research in pharmacoeconomics, pharmacoepidemiology, and patient-centered outcomes; translating and disseminating research; and educating, training, and mentoring researchers. Read more about this collaboration here.